Oral agent in second-line more than doubled median PFS in patients with ESR1 muta ...

Patients with cardiovascular-kidney-metabolic syndrome, especially those in the advanced stages at baseline, show a ...

VEPPANU™ is the first-and-only FDA-approved PROTAC, a type of heterobifunctional protein degrader –– Approval received in advance of ...

The FDA has approved the first proteolysis-targeting chimera for any oncologic indication. Vepdegestrant (Veppanu, Arvinas ...

Advanced cardiovascular-kidney-metabolic (CKM) syndrome stage, especially stages 3 and 4, is associated with increased cancer risk.

NGS utilization increased over time but left substantial proportions untested across metastatic breast, prostate, pancreatic, ...

PRISM coaching improved hope, resilience, and quality of life in AYAs with advanced cancer, with lasting benefits on anxiety and care engagement. The program includes four individual sessions and a ...

Please provide your email address to receive an email when new articles are posted on . Many patients with advanced cancer receive treatments focused on longevity, even if they prioritize comfort.

The U.S. Food and Drug Administration has approved a new treatment for advanced breast cancer. Drugmaker Eli Lilly announced Sept. 25 the approval of Inluriyo, an oral estrogen receptor antagonist, to ...

Read full article: Virginia Tech sophomore starts foundation to assist Carilion Clinic’s new Cancer Center But first they all pitched in to build handicapped access ramps. 51 minutes ago Renovation ...

Advanced cancer care does not fail at the point of discovery; it often fails at the point of distribution. The challenge is not only developing specialized treatments, but ensuring they reach patients ...